Skip to main content

Expansion of the strategic cooperation between Sanofi and C.A.PAPAELLINAS for the distribution of Sanofi Vaccines in Cyprus

Athens, Nicosia 4th April 2022. The Sanofi biopharmaceutical company announces that as of 1st January 2022 the C.A.PAPAELLINAS Group has undertaken the full representation of its Vaccines business unit in Cyprus. This agreement expands and completes the successful strategic partnership between the two organisations, which began in July 2021 with the assignment to C.A.PAPAELLINAS Group of all business operations of Sanofi’s General Medicine and Specialty Care units in the Cypriot market.

Lionel Picard

General Manager Sanofi Genzyme Greece & Cyprus, Country Lead Sanofi Greece & Cyprus

“The openness and the willingness to establish fruitful partnerships are in the Sanofi’s DNA, expressing our aim to provide medicines and vaccines that create added value for the patients and the communities in which we operate. For this reason, we are especially pleased with the strengthening of our strategic alliance with the C.A.PAPAELLINAS Group which, as the exclusive distributor of our vaccines, will ensure the continuity of the unfettered access for the Cypriot citizens to safe and effective major disease prevention solutions.”

Stelios Phinicarides

Senior General Manager – Pharma at C.A.PAPAELLINAS Group

“It is with great pleasure that we also undertake the role of the exclusive representative of Sanofi Vaccines which, along with the Pharmaceutical products of General Medicine and Specialty Care, complete the overall product portfolio of Sanofi in the Cypriot market. Our common goal of improving the patients’ quality of life and keeping Healthcare Professionals up to date with scientific information constitutes the cornerstone for the success of our cooperation, which brings forth a new opportunity to fulfil our mission: to make more and more people live and feel better.”

This agreement forms part of the wider concept of the support of the Sanofi’s partnerships with local distribution networks, a strategic decision driven by a new, modernised and more flexible business model that aims to increase the overall performance of the organisation.


With a history spanning almost a century, the C.A.PAPAELLINAS Group holds a leading position in the sectors in which it operates. These include the distribution of pharmaceutical products and the provision of relevant scientific information, as well as the promotion and distribution of cosmetics and consumer goods across a wide network of stores around Cyprus. The Pharmaceutical Sector of the Group maintains an overall quality system that sets out the responsibilities, procedures and principles of risk management at the highest level ensuring the reliable supply of medicines all over Cyprus. In addition, the highly trained personnel, with specialised knowledge and extensive experience in the Pharmaceutical Sector, the integration of new technologies and the digitalization of processes guarantee the fast and reliable provision of scientific updates for Healthcare Professionals.

Communications Department


Maritina Psara | 00 357 22 741 741 |

About Sanofi

Sanofi is an innovative global Healthcare company driven by one purpose: to chase the miracles of science to improve people’s lives. Operating in around 100 countries, the company has been committed to the transformation of the practice of medicine, turning the impossible into possible. Sanofi provides revolutionary and potentially life-saving medical treatments and protection of vaccines to millions of people around the world, while placing the sustainability and the social responsibility at the centre of its ambitions.

Sanofi is listed on the Paris Stock Exchange (EURONEXT: SAN) and the NASDAQ Stock Market (NASDAQ: SNY).

Communications Department

Sanofi Greece

Evgenia Lioni | 210 9001600 |